[The resistable rise of transdermal prevention].
Berrino
F
F
D000279:Administration, Cutaneous; D000284:Administration, Oral; D015986:Confounding Factors, Epidemiologic; D003627:Data Interpretation, Statistical; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D012107:Research Design; D012307:Risk Factors; D013997:Time Factors